首页> 外文期刊>Research Journal of Veterinary Sciences >Mechanism of Deoxyguanosine Kinase Inhibition by Nucleotide Derivatives: A Molecular Dynamic Approach
【24h】

Mechanism of Deoxyguanosine Kinase Inhibition by Nucleotide Derivatives: A Molecular Dynamic Approach

机译:核苷酸衍生物抑制脱氧鸟苷激酶的机制:分子动力学方法。

获取原文
           

摘要

Deoxyguanosine kinase is the enzyme catalyzing the first rate limiting step in the salvage pathway of purine nucleotide biosynthesis. Deoxy guanosine 5? triphosphate, (dGTP) is the axial product of the enzyme reaction. dGTP at increased concentration acts as strong inhibitor of the enzyme. dGTP also inhibits the de novo biosynthesis of purine nucleotides and consequently diminishes the cellular reservoirs of purine nucleotides. Nucleotide insufficiency induced by dGTP prevents DNA synthesis and cellular proliferation. In this way dGTP could be considered for treatment of viral infectious or even cancerous disorders. Molecular Dynamic (MD) study of deoxyguanosine kinase interaction with its inhibitors helps to survey of the structural determinant elements to design more effective inhibitors. In the present work the well known inhibitors of deoxyguanosine kinase including: deoxyguanosine (mono di and triphosphate) and deoxyinosine (mono and tri phosphate) nucleotides for a molecular dynamic simulation was used. Enzyme-Inhibitor complex were obtained using HEX docking software. The best resulting complexes from docking experiments were used for MD simulations. Enzyme-inhibitors complexes were simulated in aqueous solutions at 37°C and 1 atmosphere of pressure. The out put trajectories were used to extract the simulation data. Present results show that nucleotide inhibitors based on their binding pattern could be divided into two classes, deoxyguanosine mono and di phosphates, bind in the proximity of enzyme active site acting as competitive inhibitors and deoxyinosine mono and triphosphate and guanosine triphosphate bind in sites far from the enzyme active site and acting as non competitive inhibitors. Considering present findings it can conclude first, that dGTP the more potent inhibitor is attached to a non-competitive binding site at the C-terminus of enzyme. dGTP is interacting with the negative and positive groups on its binding site, pulling the positive and pushing negative groups of that site deforming the enzyme structure and inhibits the enzyme more effectively. Second, the more negative charges on dGTP in contrast to other inhibitors seems to promote the inhibition more pronounced.
机译:脱氧鸟苷激酶是催化嘌呤核苷酸生物合成挽救途径中第一个限速步骤的酶。脱氧鸟苷5?三磷酸(dGTP)是酶反应的轴向产物。浓度升高的dGTP可作为酶的强抑制剂。 dGTP还抑制嘌呤核苷酸的从头生物合成,因此减少了嘌呤核苷酸的细胞贮存。 dGTP诱导的核苷酸不足会阻止DNA合成和细胞增殖。通过这种方式,可以考虑使用dGTP来治疗病毒感染性甚至癌症性疾病。脱氧鸟苷激酶与其抑制剂相互作用的分子动力学(MD)研究有助于调查结构决定因素,以设计更有效的抑制剂。在本工作中,使用了众所周知的脱氧鸟苷激酶抑制剂,包括:脱氧鸟苷(单磷酸和三磷酸)和脱氧肌苷(单磷酸和三磷酸)核苷酸,用于分子动力学模拟。使用HEX对接软件获得了酶-抑制剂复合物。通过对接实验获得的最佳复合物用于MD模拟。在水溶液中于37°C和1个大气压下模拟酶抑制剂复合物。输出轨迹用于提取仿真数据。目前的结果表明,基于其结合方式的核苷酸抑制剂可分为两类:脱氧鸟苷单磷酸和二磷酸,在作为竞争性抑制剂的酶活性位点附近结合,而脱氧肌苷单磷酸和三磷酸以及鸟苷三磷酸在远离结合位点的位置结合。酶活性位点,起非竞争性抑制剂的作用。考虑到目前的发现,它可以首先得出结论,即更有效的抑制剂dGTP在酶的C端附着于非竞争性结合位点。 dGTP在其结合位点上与阴性和阳性基团相互作用,拉动该位点的阳性和阴性基团会使酶结构变形并更有效地抑制酶。其次,与其他抑制剂相比,dGTP上更多的负电荷似乎更明显地促进了抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号